ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 279503 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 279503; 2) Community: the network communities that were significantly associated with the response to NSC 279503; 3) Molecule: the relationships between components within communities and NSC 279503; 4) MDR: the compounds that were significantly associated with the NSC 279503.

NSC Compound Enrichment Correlation
NSC 748541 1-Methylene-2-(4-methoxybenzyl)-3-(3-chlorophenyl)-1,2-dihydropyrazino[1,2-a]-benzimidazole 0.0102077332082017 0.23844812
NSC 751958 (2E)-2-(all-trans retinylidene)-N-{[(2E)-2-(all-trans retinylidene)hydrazinyl]carbonothioyl}hydrazinecarbothioamide N3-monosodium salt heminonahydrate 0.0102077332082017 0.31862573
NSC 754118 6-chloro-7-phenyl-8-(3,5-dimethoxybenzyl)- 5,8-dihydro-4H-isoxazolo[4,5-g]indole 0.0102077332082017 0.4075909
NSC 754596 6-imino-3-methoxy 4-azaisoindole[2,1-a]quinoxaline 0.0102077332082017 0.24851925
NSC 75520 Thymidine, .alpha.,.alpha.,.alpha.-trifluoro- (8CI 9CI) 0.0102077332082017 0.31361115
NSC 87500 Solacongestidine 0.0102077332082017 0.26303614
NSC 93354 Null 0.0102077332082017 0.2581298
NSC 338643 6-Phenyl-6H-indeno[1,2-c]isoquinoline-5,11-dione 0.0102962192514438 -0.23968145
NSC 339638 2H-Pyran-2-one, 5,6-dihydro-6-[3,6,13-trihydroxy-3-methyl- 4-(phosphonooxy)-1,7,9,11-tridecatetraenyl]-, monosodiumsalt 0.0102962192514438 0.25517909
NSC 617826 Null 0.0102962192514438 0.20640343
Total:146  Current:43    [First] [Prev] [Next] [Last]